Q. Consider the following statements regarding Zycov-D vaccine
1. It is the world’s first and India’s indigenously developed DNA based vaccine for COVID-19.
2. The vaccine is an intradermal vaccine which means it is applied using a ‘needle-free injector’.
3. Zycov-D will be given in single dose
Which of the above statements is/are correct?

[A] 1 and 2 only

[B] 2 and 3 only

[C] 1 and 3 only

[D] All of the above

Answer: A
Notes:

Drugs Controller General of India’s (DCGI’s) has granted emergency approval for Zycov-D vaccine. 

About Zycov-D: 

  • Zycov-D is a DNA plasmid-based Covid-19 vaccine developed by Zycov Cadilla Group in partnership with the Department of Biotechnology under the ‘Mission COVID Suraksha’. 
  • It is the world’s first and India’s indigenously developed DNA based vaccine for COVID-19. 
  • The vaccine is an intradermal vaccine which means it is applied using a ‘needle-free injector’. 
  • The vaccine is to be administered in humans, including Children and adults 12 years and above. 
  • Unlike other Covid-19 vaccines which are given in two doses, Zycov-D will be given in three doses with an interval of 28 days between each dose. 

Read more: Zydus Cadila vaccine gets emergency nod